General Information of the Compound
Compound ID
CP0486693
Compound Name
4-[2-[1-(4-methoxyphenyl)-5-methylpyrazol-3-yl]oxyethyl]morpholine
    Show/Hide
Structure
Formula
C17H23N3O3
Molecular Weight
317.389
Canonical SMILES
COc1ccc(cc1)-n1nc(OCCN2CCOCC2)cc1C
    Show/Hide
InChI
InChI=1S/C17H23N3O3/c1-14-13-17(23-12-9-19-7-10-22-11-8-19)18-20(14)15-3-5-16(21-2)6-4-15/h3-6,13H,7-12H2,1-2H3
    Show/Hide
InChIKey
MLMSXMUNOAHWMJ-UHFFFAOYSA-N
Physicochemical Property
logP
1.90032
Rotatable Bonds
6
Heavy Atom Count
23
Polar Areas
48.75
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11544226
SID: 16646402
ChEMBL ID
CHEMBL2170058
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki > 1000 nM
   TI
   LI
   LO
   TS